The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Abbott, a manufacturer of diagnostics and medical devices, sent a film crew to highlight Auburn Community Hospital's ...

Abbott has been investing in structural heart products and recently entered the fast-growing left atrial appendage closure market. Despite falling behind in the race for pulsed field ablation ...

ABT's shares rise on the back of its diversified business portfolio. However, the unfavorable macroeconomic scenario is concerning.

In the most recent trading session, Abbott (ABT) closed at $127.42, indicating a +0.89% shift from the previous trading day.

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Texas legislature reverses course on THC ...

Gov. Greg Abbott declined to endorse Lt. Gov. Dan Patrick’s THC ban on Thursday, saying he needs more information about how lawmakers propose a prohibition that would criminalize a fast-growing ...

Gov. Greg Abbott did not endorse a ban on THC, citing the need for more information on the potential effects of the ...

Governor Greg Abbott announced that the fifth Texas Semiconductor Innovation Fund grant of $17.3 million will be awarded to ...